Jim Simons’s Medline Inc MDLN Stock Holding History

Jim Simons’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.39M	Buy	+143,700	New	+$6.34M	0.01%	1220

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Jim Simons's MDLN Position: Q1 2026 in Review

Jim Simons opened a new position in Medline Inc (MDLN) in Q1 2026: 143,700 shares worth $6.39M. The stake represents 0.01% of the portfolio and ranks #1220 among its holdings.

314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Jim Simons held 143,700 shares of Medline Inc worth $6.39M as of Q1 2026.
Medline Inc was a new Jim Simons position in Q1 2026.
Medline Inc made up 0.01% of Jim Simons's portfolio in Q1 2026, its #1220 holding.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.